rtfMRI neurofeedback interventions are not cost prohibitive
Evidence is accumulating that real-time fMRI neurofeedback is an effective treatment for various psychiatric disorders, including major depressive disorder (MDD). However, it is often dismissed as too expensive to ever be available clinically. This special communication compares the cost of real-tim...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-03-01
|
| Series: | Psychiatry Research Communications |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2772598725000029 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832542421181792256 |
|---|---|
| author | Kymberly D. Young |
| author_facet | Kymberly D. Young |
| author_sort | Kymberly D. Young |
| collection | DOAJ |
| description | Evidence is accumulating that real-time fMRI neurofeedback is an effective treatment for various psychiatric disorders, including major depressive disorder (MDD). However, it is often dismissed as too expensive to ever be available clinically. This special communication compares the cost of real-time functional magnetic resonance imaging neurofeedback to both standard and novel interventions for MDD.While SSRI medications remain the most inexpensive treatment option, all other available treatments for major depressive disorder cost as much or more than a course of fMRI neurofeedback. It is concluded that rtfMRI neurofeedback is not cost prohibitive and should not be dismissed for this reason. |
| format | Article |
| id | doaj-art-0ad781eacfdb4563a287daaa3a32b9ba |
| institution | Kabale University |
| issn | 2772-5987 |
| language | English |
| publishDate | 2025-03-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Psychiatry Research Communications |
| spelling | doaj-art-0ad781eacfdb4563a287daaa3a32b9ba2025-02-04T04:10:42ZengElsevierPsychiatry Research Communications2772-59872025-03-0151100203rtfMRI neurofeedback interventions are not cost prohibitiveKymberly D. Young0University of Pittsburgh School of Medicine, Pittsburgh, 15213, PA, USAEvidence is accumulating that real-time fMRI neurofeedback is an effective treatment for various psychiatric disorders, including major depressive disorder (MDD). However, it is often dismissed as too expensive to ever be available clinically. This special communication compares the cost of real-time functional magnetic resonance imaging neurofeedback to both standard and novel interventions for MDD.While SSRI medications remain the most inexpensive treatment option, all other available treatments for major depressive disorder cost as much or more than a course of fMRI neurofeedback. It is concluded that rtfMRI neurofeedback is not cost prohibitive and should not be dismissed for this reason.http://www.sciencedirect.com/science/article/pii/S2772598725000029NeurofeedbackfMRICost |
| spellingShingle | Kymberly D. Young rtfMRI neurofeedback interventions are not cost prohibitive Psychiatry Research Communications Neurofeedback fMRI Cost |
| title | rtfMRI neurofeedback interventions are not cost prohibitive |
| title_full | rtfMRI neurofeedback interventions are not cost prohibitive |
| title_fullStr | rtfMRI neurofeedback interventions are not cost prohibitive |
| title_full_unstemmed | rtfMRI neurofeedback interventions are not cost prohibitive |
| title_short | rtfMRI neurofeedback interventions are not cost prohibitive |
| title_sort | rtfmri neurofeedback interventions are not cost prohibitive |
| topic | Neurofeedback fMRI Cost |
| url | http://www.sciencedirect.com/science/article/pii/S2772598725000029 |
| work_keys_str_mv | AT kymberlydyoung rtfmrineurofeedbackinterventionsarenotcostprohibitive |